Clover Biopharmaceuticals, Ltd. (2197.HK)

HKD 0.2

(4.81%)

Revenue Summary of Clover Biopharmaceuticals, Ltd.

  • Clover Biopharmaceuticals, Ltd.'s latest annual revenue in 2023 was 39.25 Million CNY , down 0.0% from previous year.
  • Clover Biopharmaceuticals, Ltd.'s latest quarterly revenue in 2024 Q2 was -5.05 Million CNY , down 0.0% from previous quarter.
  • Clover Biopharmaceuticals, Ltd. reported a annual revenue of - CNY in annual revenue 2022, down 0.0% from previous year.
  • Clover Biopharmaceuticals, Ltd. reported a annual revenue of - CNY in annual revenue 2021, down 0.0% from previous year.
  • Clover Biopharmaceuticals, Ltd. reported a quarterly revenue of -5.05 Million CNY for 2024 Q2, down 0.0% from previous quarter.
  • Clover Biopharmaceuticals, Ltd. reported a quarterly revenue of 39.25 Million CNY for 2023 FY, down 0.0% from previous quarter.

Annual Revenue Chart of Clover Biopharmaceuticals, Ltd. (2023 - 2019)

Historical Annual Revenue of Clover Biopharmaceuticals, Ltd. (2023 - 2019)

Year Revenue Revenue Growth
2023 39.25 Million CNY 0.0%
2022 - CNY 0.0%
2021 - CNY 0.0%
2020 - CNY 0.0%
2019 - CNY 0.0%

Peer Revenue Comparison of Clover Biopharmaceuticals, Ltd.

Name Revenue Revenue Difference
Uni-Bio Science Group Limited 484.71 Million HKD 91.901%
CK Life Sciences Int'l., (Holdings) Inc. 5.32 Billion HKD 99.263%